NCT02695849View on ClinicalTrials.gov

A Study of Prevalence of EGFR Mutations in Participants With NSCLC

CompletedOBSERVATIONAL
Enrollment

69

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Non-Small Cell Lung Cancer
Trial Locations (2)

11941

Amman

13046 / 11942

Amman

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02695849 - A Study of Prevalence of EGFR Mutations in Participants With NSCLC | Biotech Hunter | Biotech Hunter